PAK1 and cancer: In breast cancer and gliomas, HOXD10 downregulation results in the downregulation of miR-7 and upregulation of p21-activated kinase 1 expression (PAK1), which culminates in higher aggressiveness of these cancer types facilitating invasion and metastasis [111].